Background : Columnar cell lesions (CCLs) are characterized by the presence of columnar epithelial cells lining the terminal duct lobular units of the breast and frequently found in biopsies for microcalcifications. Their incidence and relationship with other lesions and the locations of microcalcifications have not been established. Methods : We reviewed 1,038 cases of fibrocystic change (FCC) for the degrees of CCLs and ductal proliferative change (PC) and the locations of microcalcifications. Results : Among 1,038 FCC cases, CCLs were found in 18.9%, columnar cell change (CCC) in 12.5%, columnar cell hyperplasia (CCH) in 5.3% and flat epithelial atypia (FEA) in 1.1%. CCLs were found in 14.2%, 28.8%, and 40.0% of non-PC (NPC), proliferative disease (PD) without atypia and PD with atypia, respectively. Microcalcifications were found in 33.5%, 56.2%, 61.8%, and 81.8% of caese without CCLs, with CCC, CCH and FEA, respectively. Their locations were in NPC in 66.3% of the cases, PD in 14.8% of the cases or both areas in 18.8% of FCC. Conclusions : The incidence of CCLs increased according to the degree of PD without positive correlation between the degree of CCLs and PD. The frequency of microcalcifications increased according to the degree of CCLs but was statistically insignificant. There is a possibility that a needle biopsy targeting a microcalcification area might leave additional PD around the targeted area because microcalcifications were found more frequently in NPC than PD area.
Since columnar cell lesions (CCLs) were first described in the literature by Foote in 1945 1 as blunt duct adenosis, they were known by various names such as columnar cell metaplasia, 2 atypical lobule type A, 3 monomorphic type of clinging carcinoma, 4 columnar alteration of lobule, 5 cancerization of small ectatic ducts, 6 columnar alteration with prominent apical snouts and secretions, 7 atypical cystic lobule, 8 columnar cell change (CCC) and hyperplasia (CCH), 9 atypical cystic duct, 10 flat epithelial atypia (FEA), 11 and enlarged lobular unit with columnar alteration. 12 They are characterized by a presence of columnar shaped epithelial cells lining terminal duct lobular units without or with variable degrees of epithelial hyperplasia and recently classified as CCC, CCH and CCH with atypia (FEA) according to the degree of cellular hyperplasia and nuclear atypia. [13] [14] [15] [16] [17] [18] They are increasingly found in biopsies taken for microcalcifications on mammography, but their incidence among benign breasts and the relationship between CCLs and microcalcifications or ductal hyperplasia (DH) are not established yet. They are assumed to be associated with lobular or ductal lesions of breast and have an increased risk for cancer when accompanied by atypia. 9, 13, 14, [19] [20] [21] [22] [23] Therefore, we investigated the incidence of this lesion among fibrocystic change (FCC) and its relationship with ductal proliferative disease (PD) and with microcalcifications.
MATERIAL AND METHODS
The files of Inje University Pusan Paik Hospital, Department of Pathology were searched for FCC diagnosis by excisional biopsy or mammotome excision from January to December, 2004. We excluded the cases with accompanying fibroadenoma, papilloma or inflammatory lesions. H&E stained slides were reviewed by two pathologists for the presence and degrees of CCLs, the degrees of accompanying PD, and the presence and locations of microcalcifications. CCLs were classified into CCC, CCH and FEA according to Schnitt and Vincent-Salomon (Fig. 1) . 24 The degrees of PD were classified into non-proliferative change (NPC), PD without atypia PD with atypia according to Kumar et al. 25 The locations of microcalcifications were classified into 'PD' when microcalcifications were within the areas of PD, 'NPC' when they were in area of NPC, 'both' when they were in both PD and NPC areas (Fig. 1 ).
Statistical analysis
For statistical evaluation, the relationships were assessed by chi-square test using the SAS 8.0 statistical software program (SAS Institute, NC, USA). And the trend was assessed by chisquare test for trend using MedCalc ver.10.0.2 (Medcalc Software bvba, Mariakerke, Belgium). A p-value below 0.05 was considered as statistically significant.
RESULTS
A total of 1,038 cases of FCC without or with PD excluding cases with accompanying neoplastic or inflammatory conditions were reviewed. The relationship between CCLs and PD among FCC
The incidence of CCLs increased to 104 (14.2%), 76 (28.8%) and 16 (40.0%) for NPC, PD without atypia and PD with atypia, respectively (p<0.0001, chi-square test for trend), but there was no correlation between the degrees of CCLs and degrees of PD (p=0.4361) ( Table 1) .
Relationship between CCLs and microcalcifications
Microcalcifications were found in 398 cases (38.3%) of FCC. They were more frequently found in cases with CCLs (59.2%) than in cases without them (33.5%) (p<0.0001). Their frequency increased to 282 (33.5%), 73 (56.2%), 34 (61.8%), and 9 (81.8 %) for cases without CCLs, with CCC, CCH and FEA, respectively (p<0.0001, chi-square test for trend). But among CCLs, there was no correlation between the degrees of CCLs and the presence of microcalcifications (p=0.2248, chi-square test for trend) ( Table 2 ).
The locations of microcalcifications
Microcalcifications were found in NPC in 264 cases (66.3%), in PD in 59 cases (14.8%) or in both areas in 75 cases (18.9%) of FCC. They were more frequently found in the area of NPC (49 cases, 42.2%) than within PD (25 cases, 22.4%) of CCLs and these findings were more pronounced among cases without CCLs having 215 cases (76.2%) in the NPC area and 33 cases (11.7%) within PD area (Table 3) .
DISCUSSION
CCLs consist of a spectrum of changes to the terminal duct lobular unit of the breast ranging from bland columnar alteration through CCH to FEA. The classification of these lesions was not established yet, and recently Schnitt proposed a system consisting of four categories and later simplified it into three categories. CCC is a variable dilation of the terminal duct lobular unit lined by one or two layers of uniform ovoid to elongated nuclei oriented perpendicular to the basement membrane. CCH shows a cellular stratification with more than two cell layers without complex architectural patterns. They may show prominent apical snouts, luminal secretions and microcalcifications. FEA shows epithelial cells replaced by one to several layers of monotonous, atypical cuboidal to columnar cells. The degree of atypia is subtle and falls short of diagnosis for atypical DH.
In 1945, Foote and Stewart stated that blunt duct adenosis was found in 26% of non-cancerous and 26% of cancerous breasts.
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Since then their incidence rate is not known. These lesions, especially bland CCC, are difficult to notice by microscopic examination on a low power view. We found CCLs in 18.9% of FCC. CCC, CCH and FEA were found in 12.5%. 5.3%, and 1.1% of FCC, respectively.
Although the significance of CCLs have not been reported in the literature yet, it is assumed that they, especially FEA, are morphologic initial steps or precursors to ductal carcinoma in situ, 14, 19, 21, 23, 26 or associated with lobular neoplasia or tubular carcinoma. 9, 13, 20, 22 Since we confined this study to benign lesions, the relationship with malignancy cannot be determined. In our study, the incidence of CCLs was higher when the degree of proliferation was higher, but there was no positive correlation between the degree of CCLs and the degree of PD (p=0.4361). The cases accompanying lobular hyperplasia were also found in 7 out of 1,038 cases, and 2, 2, 2, and 1 cases were without CCLs, with CCC, CCH, and FEA, respectively. As the cases with lobular carcinoma in situ or invasive lobular carcinoma were not included in our study which was done with benign lesions and their numbers are so few, we cannot determine the relationship between the degree of lobular hyperplasia and CCLs. 
